Literature DB >> 10929873

Complicated urinary tract infections.

M D Melekos1, K G Naber.   

Abstract

The term complicated urinary tract infection is usually used to convey an infection that occurs in a patient with a structural or functional abnormality impeding urine flow, or in a host with altered defences. The distinction between complicated and uncomplicated infections is important because, when complicating factors are present, antimicrobial resistance is more common and the response to therapy is often disappointing, even with agents active against the causative microbial pathogen. In addition, severe complications frequently occur which may lead to urosepsis, renal scarring or even end-stage disease. Drug treatment of complicated urinary tract infections often must be complemented with endoscopic and/or surgical intervention. Only a few well designed treatment studies have been published and therefore sources for definitive therapeutic guidelines remain inadequate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10929873     DOI: 10.1016/s0924-8579(00)00168-0

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  13 in total

1.  Antimicrobial Resistance and Molecular Characterization of Extended-Spectrum β-Lactamases of Escherichia coli and Klebsiella spp. Isolates from Urinary Tract Infections in Southern Brazil.

Authors:  Juliano Lacava Pereira; Lisiane Martins Volcão; Gabriel Baracy Klafke; Roseli Stone Vieira; Carla Vitola Gonçalves; Ivy Bastos Ramis; Pedro Eduardo Almeida da Silva; Andrea von Groll
Journal:  Microb Drug Resist       Date:  2018-08-22       Impact factor: 3.431

2.  Crosstalk between TGF-β1 and CXCR3 signaling during urethral fibrosis.

Authors:  Hong Xie; Chao Feng; Qiang Fu; Ying-Long Sa; Yue-Min Xu
Journal:  Mol Cell Biochem       Date:  2014-06-07       Impact factor: 3.396

Review 3.  Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.

Authors:  Valerie P O'Brien; Thomas J Hannan; Anthony J Schaeffer; Scott J Hultgren
Journal:  Curr Opin Infect Dis       Date:  2015-02       Impact factor: 4.915

Review 4.  Urinary tract infections in adult general practice patients.

Authors:  Eva Hummers-Pradier; Michael M Kochen
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

5.  Prulifloxacin.

Authors:  Susan J Keam; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.

Authors:  Culley Carson; Kurt G Naber
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  A Cohort Study of Risk Factors That Influence Empirical Treatment of Patients with Acute Pyelonephritis.

Authors:  Pau Bosch-Nicolau; Vicenç Falcó; Belén Viñado; Antonia Andreu; Oscar Len; Benito Almirante; Carles Pigrau
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

Review 8.  Management of bacterial urinary tract infections in adult patients with diabetes mellitus.

Authors:  Ruby Meiland; Suzanne E Geerlings; Andy I M Hoepelman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Invasion and translocation of uropathogenic Escherichia coli isolated from urosepsis and patients with community-acquired urinary tract infection.

Authors:  B Owrangi; N Masters; A Kuballa; C O'Dea; T L Vollmerhausen; M Katouli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-16       Impact factor: 3.267

10.  Microbiological Analysis of Urine Cultures in Women after Pelvic Reconstructive Surgery.

Authors:  Melissa L Dawson; Meagan S Cramer; Dana R Thompson; Babak Vakili
Journal:  Curr Urol       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.